Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains
2H-Benzo[e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide (BTD) based carbonic anhydrase (CA) inhibitors are here explored as new anti-mycobacterial agents. The chemical features of BTD derivatives meet the criteria for a potent inhibition of β-class CA isozymes. BTD derivatives show chemical features meeting the criteria for a potent inhibition of β-class CA isozymes. Specifically, three β-CAs (MtCA1, MtCA2, and MtCA3) were identified in Mycobacterium tuberculosis and their inhibition was shown to exert an antitubercular action. BTDs derivatives 2a-q effectively inhibited the mycobacterial CAs, especially MtCA2 and MtCA3, with Ki values up to a low nanomolar range (MtCA3, Ki = 15.1-2250 nM; MtCA2, Ki = 38.1-4480 nM) and with a significant selectivity ratio over the off-target human CAs I and II. A computational study was conducted to elucidate the compound structure-activity relationship. Importantly, the most potent MtCA inhibitors demonstrated efficacy in inhibiting the growth of M. tuberculosis strains resistant to both rifampicin and isoniazid-standard reference drugs for Tuberculosis treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
International journal of molecular sciences - 25(2024), 5 vom: 23. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bua, Silvia [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 14.03.2024 Date Revised 15.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/ijms25052584 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369635450 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369635450 | ||
003 | DE-627 | ||
005 | 20240315233800.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240313s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/ijms25052584 |2 doi | |
028 | 5 | 2 | |a pubmed24n1330.xml |
035 | |a (DE-627)NLM369635450 | ||
035 | |a (NLM)38473830 | ||
035 | |a (PII)2584 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bua, Silvia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.03.2024 | ||
500 | |a Date Revised 15.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a 2H-Benzo[e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide (BTD) based carbonic anhydrase (CA) inhibitors are here explored as new anti-mycobacterial agents. The chemical features of BTD derivatives meet the criteria for a potent inhibition of β-class CA isozymes. BTD derivatives show chemical features meeting the criteria for a potent inhibition of β-class CA isozymes. Specifically, three β-CAs (MtCA1, MtCA2, and MtCA3) were identified in Mycobacterium tuberculosis and their inhibition was shown to exert an antitubercular action. BTDs derivatives 2a-q effectively inhibited the mycobacterial CAs, especially MtCA2 and MtCA3, with Ki values up to a low nanomolar range (MtCA3, Ki = 15.1-2250 nM; MtCA2, Ki = 38.1-4480 nM) and with a significant selectivity ratio over the off-target human CAs I and II. A computational study was conducted to elucidate the compound structure-activity relationship. Importantly, the most potent MtCA inhibitors demonstrated efficacy in inhibiting the growth of M. tuberculosis strains resistant to both rifampicin and isoniazid-standard reference drugs for Tuberculosis treatment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Mycobacterium | |
650 | 4 | |a carbonic anhydrase | |
650 | 4 | |a drug resistance | |
650 | 4 | |a inhibitors | |
650 | 4 | |a molecular modelling | |
650 | 7 | |a Carbonic Anhydrase Inhibitors |2 NLM | |
650 | 7 | |a Isoenzymes |2 NLM | |
650 | 7 | |a Carbonic Anhydrases |2 NLM | |
650 | 7 | |a EC 4.2.1.1 |2 NLM | |
650 | 7 | |a Antitubercular Agents |2 NLM | |
650 | 7 | |a Carbonic Anhydrase IX |2 NLM | |
650 | 7 | |a EC 4.2.1.1 |2 NLM | |
700 | 1 | |a Bonardi, Alessandro |e verfasserin |4 aut | |
700 | 1 | |a Mük, Georgiana Ramona |e verfasserin |4 aut | |
700 | 1 | |a Nocentini, Alessio |e verfasserin |4 aut | |
700 | 1 | |a Gratteri, Paola |e verfasserin |4 aut | |
700 | 1 | |a Supuran, Claudiu T |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 25(2024), 5 vom: 23. Feb. |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2024 |g number:5 |g day:23 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms25052584 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2024 |e 5 |b 23 |c 02 |